Home
Aquestive Therapeutics AQST paid Rubicon Advisors $45K for lobbying in Q1 2023 · Pharmacy
Trade details
- Type
- Lobbying report
- Amount
- $45,000
- Quarter
- Q1 2023
- Client
- Aquestive Therapeutics
- Reported
- 23/04/20
Up 0.0% from last quarter
What else happened in Aquestive Therapeutics around then
Filed or reported within 30 days of the trade day · 23/03/01~23/04/30Aquestive Therapeutics's other lobbying reports
- Aquestive Therapeutics
LobbyingAquestive Therapeutics
LobbyingAquestive Therapeutics
AQST
$60K
$60K
Reported 07/16
for Q2
- Aquestive Therapeutics
LobbyingAquestive Therapeutics
LobbyingAquestive Therapeutics
AQST
$60K
$60K
Reported 04/17
for Q1
- Aquestive Therapeutics
LobbyingAquestive Therapeutics
LobbyingAquestive Therapeutics
AQST
$60K
$60K
Reported 01/20
for Q4 2025
- Aquestive Therapeutics
LobbyingAquestive Therapeutics
LobbyingAquestive Therapeutics
AQST
$50K
$50K
Reported 25/10/20
for Q3 2025
- Aquestive Therapeutics
LobbyingAquestive Therapeutics
LobbyingAquestive Therapeutics
AQST
$30K
$30K
Reported 25/07/21
for Q2 2025